Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.

Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R.

Mod Pathol. 2008 Feb;21(2):192-200. Epub 2007 Dec 14.

2.

PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.

Bishop JA, Sharma R, Westra WH.

Hum Pathol. 2011 Dec;42(12):1873-7. doi: 10.1016/j.humpath.2011.02.004. Epub 2011 Jun 12.

PMID:
21663937
3.

Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.

Suzuki A, Hirokawa M, Takada N, Higuchi M, Yamao N, Kuma S, Daa T, Miyauchi A.

Endocr J. 2015;62(11):991-5. doi: 10.1507/endocrj.EJ15-0226. Epub 2015 Sep 9.

4.

Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.

Batista FA, Ward LS, Marcello MA, Martins MB, Peres KC, Torricelli C, Bufalo NE, Soares FA, da Silva MJ, Assumpção LV.

J Endocrinol Invest. 2016 Apr;39(4):423-9. doi: 10.1007/s40618-015-0386-4. Epub 2015 Sep 14.

PMID:
26370671
5.

Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.

Chernock RD, El-Mofty SK, Becker N, Lewis JS Jr.

Am J Surg Pathol. 2013 Aug;37(8):1215-22. doi: 10.1097/PAS.0b013e318283b7b2.

PMID:
23681073
6.

Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors.

Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kakudo K.

Pathol Int. 2006 May;56(5):240-5.

PMID:
16669872
7.
8.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

9.

Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.

Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G.

Cancer Res. 1994 Sep 1;54(17):4744-9.

10.

Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.

Santos JE, Kalk WJ, Freitas M, Marques Carreira I, Castelo Branco M.

BMC Res Notes. 2015 Jul 1;8:284. doi: 10.1186/s13104-015-1155-3.

11.

Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.

Boos LA, Dettmer M, Schmitt A, Rudolph T, Steinert H, Moch H, Sobrinho-Simões M, Komminoth P, Perren A.

Histopathology. 2013 Aug;63(2):234-41. doi: 10.1111/his.12150. Epub 2013 Jun 6.

PMID:
23738683
12.

Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.

Buergy D, Weber T, Maurer GD, Mudduluru G, Medved F, Leupold JH, Brauckhoff M, Post S, Dralle H, Allgayer H.

Int J Cancer. 2009 Aug 15;125(4):894-901. doi: 10.1002/ijc.24462.

13.

A comprehensive analysis of PAX8 expression in human epithelial tumors.

Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, Drapkin R, Hirsch MS.

Am J Surg Pathol. 2011 Jun;35(6):816-26. doi: 10.1097/PAS.0b013e318216c112.

PMID:
21552115
14.

The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.

El-Maqsoud NM, Tawfiek ER, Abdelmeged A, Rahman MF, Moustafa AA.

Tumour Biol. 2016 Mar;37(3):3123-34. doi: 10.1007/s13277-015-3964-3. Epub 2015 Oct 1.

PMID:
26427663
15.

Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.

Puglisi F, Cesselli D, Damante G, Pellizzari L, Beltrami CA, Di Loreto C.

Anticancer Res. 2000 Jan-Feb;20(1A):311-6.

PMID:
10769673
16.

PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.

Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, Truong LD.

Mod Pathol. 2011 Jun;24(6):751-64. doi: 10.1038/modpathol.2011.3. Epub 2011 Feb 11.

17.

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE.

Am J Surg Pathol. 2002 Aug;26(8):1016-23.

PMID:
12170088
18.

PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.

Bellevicine C, Iaccarino A, Malapelle U, Sasso FC, Biondi B, Troncone G.

Eur J Endocrinol. 2013 Jul 29;169(3):307-11. doi: 10.1530/EJE-13-0150. Print 2013 Sep.

19.

Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.

Ramos-Vara JA, Frank CB, DuSold D, Miller MA.

J Comp Pathol. 2016 Nov;155(4):286-298. doi: 10.1016/j.jcpa.2016.07.009. Epub 2016 Aug 24.

PMID:
27567273
20.

Supplemental Content

Support Center